These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24236345)

  • 21. [Polycystic kidney disease with autosomal dominant transmission].
    Muşat S
    Rev Med Chir Soc Med Nat Iasi; 1992; 96 Suppl():19-23. PubMed ID: 1305323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular genetic diagnosis of autosomal dominant polycystic kidney disease].
    Reiterová J; Merta M; Stekrová J; Tesar V
    Sb Lek; 2002; 103(4):435-42. PubMed ID: 12688156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystic disease in women: clinical characteristics and medical management.
    Chapman AB
    Adv Ren Replace Ther; 2003 Jan; 10(1):24-30. PubMed ID: 12616460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [CME: Autosomal dominant polycystic kidney disease].
    Schnoz C; P Wüthrich R
    Praxis (Bern 1994); 2016 Mar; 105(6):305-11. PubMed ID: 26980680
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal artery embolization for the symptomatic treatment of adult polycystic kidney disease.
    Bremmer MS; Jacobs SC
    Nat Clin Pract Nephrol; 2008 May; 4(5):236-7. PubMed ID: 18317502
    [No Abstract]   [Full Text] [Related]  

  • 26. [Two cases of autosomal dominant polycystic kidney diseases who presented bilateral enlarged kidneys and severe hypertension in the neonatal period].
    Wakaki H; Ikeda M; Hataya H; Ishikura K; Nakashima T; Oosako Y; Honda M
    Nihon Jinzo Gakkai Shi; 2004 Oct; 46(7):719-23. PubMed ID: 15570901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Two cases of autosomal dominant polycystic kidney disease treated with hemodialysis associated with polycystic liver complications related to the cause of death].
    Saima S; Suzuki Y; Yoshimoto K; Nakamura Y; Munakata A
    Nihon Jinzo Gakkai Shi; 1996 Jun; 38(6):278-84. PubMed ID: 8752971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
    Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
    Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renal polycystosis in pediatrics].
    Khoory BJ; Fanos V
    Pediatr Med Chir; 1998; 20(4):269-73. PubMed ID: 9866850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autosomal dominant polycystic kidney disease: emerging concepts of pathogenesis and new treatments.
    Braun WE
    Cleve Clin J Med; 2009 Feb; 76(2):97-104. PubMed ID: 19188475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical management of autosomal dominant polycystic kidney disease.
    Bennett WM; Elzinga LW
    Kidney Int Suppl; 1993 Jul; 42():S74-9. PubMed ID: 8361135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular diagnostics of ADPKD coming of age.
    Harris PC; Rossetti S
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):1-2. PubMed ID: 18178778
    [No Abstract]   [Full Text] [Related]  

  • 33. [Transcatheter arterial embolization (TAE) therapy on a patient with polycystic kidney disease].
    Suwabe T; Sumida K; Hayami N; Hoshino J; Ubara Y
    Nihon Jinzo Gakkai Shi; 2012; 54(4):522-8. PubMed ID: 24236344
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular diagnosis of autosomal dominant polycystic kidney disease.
    Torra Balcells R; Ars Criach E
    Nefrologia; 2011; 31(1):35-43. PubMed ID: 21270911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autosomal dominant polycystic kidney disease: light at the end of the tunnel?].
    Melander C; Joly D; Knebelmann B
    Nephrol Ther; 2010 Jul; 6(4):226-31. PubMed ID: 20430712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The molecular genetic analysis of polycystic kidney disease].
    Fukuda Y
    Nihon Rinsho; 1992 Dec; 50(12):3093-9. PubMed ID: 1283420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
    Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
    Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retroperitoneoscopic nephrectomy as a second-line treatment after transarterial embolization for symptomatic autosomal dominant polycystic kidney disease.
    Akamatsu S; Kinoshita H; Shimizu Y; Yoshimura K; Ito N; Kamoto T; Ogawa O
    Hinyokika Kiyo; 2006 Dec; 52(12):947-50. PubMed ID: 17252979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the effects of ramipril and losartan on blood pressure control and left ventricle hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Ulusoy S; Ozkan G; Orem C; Kaynar K; Koşucu P; Kiriş A
    Ren Fail; 2010; 32(8):913-7. PubMed ID: 20722556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic kidney disease: hereditary and acquired.
    Grantham JJ
    Adv Intern Med; 1993; 38():409-20. PubMed ID: 8438648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.